Physician profile
Jonathan W Ditkoff
NPI 1386600823
$1,622.95
in general payments reported to CMS, 2019-2025
12 companies · $56.88 in 2025
The $56.88 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $71.14 · 2021: $269 · 2022: $234 · 2023: $506 · 2024: $319 · 2025: $56.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $672.96 | 2023-2024 | Actifuse, Floseal |
| Allergan, INC. | $216.74 | 2019-2022 | |
| Abbvie INC. | $139.46 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Glaukos Corporation | $128.33 | 2022 | |
| New World Medical,INC. | $123.04 | 2021 | |
| Sight Sciences, INC. | $109.01 | 2019 | |
| Biotissue Holdings INC. | $102.44 | 2022-2023 | |
| Alcon Vision LLC | $56.97 | 2022 | |
| Aerie Pharmaceuticals, INC. | $29.46 | 2019 | |
| Kala Pharmaceuticals, INC. | $16.30 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.13 | 2020 | |
| Sun Pharmaceutical Industries INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ditkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.